Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afatinib plus vinorelbine vs trastuzumab plus vinorelbine in HER2-positive metastatic breast cancer
CTR20130095Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of afatinib in breast cancer, sponsored by Boehringer Ingelheim. Started Aug 2014; status: completed.
02
Drugs
afatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20130095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130095.